SUBSCRIBE
SUBSCRIBE

Jon Chesnut

Pictured: gene editing on DNA Background / Taylor
Drug Development
Opinion: The Promise and Challenges of CRISPR-Based Treatments
With last year’s approval of Vertex and CRISPR’s Casgevy, it’s the start of a new era of gene editing. But there are still challenges we must face.
February 13, 2024
 · 
3 min read
 · 
Jon Chesnut